ENVB - מכפיל P/S עתידי Enveric Biosciences, Inc.
Enveric Biosciences (ENVB) is currently in the early research stage of psychopharmacology without active profit generators. Geopolitical fragmentation limits the export of psychedelics and hinders global research. However, streamlined cross-border raw material logistics ensure high margins. The projected P/S metric reflects market revenue expectations, with the latest value recorded as .
פילוחי נתונים אנליטיים מרוכזים עבור Enveric Corp (ENVB)
The forward P/S reflects market expectations regarding business value by comparing current capitalization with projected sales volume. Analyzing the forward P/S valuation at , an investor sees a premium for future growth, which for the non-cyclical biotech Enveric Biosciences (ENVB) depends not on macroeconomics, but on the volume of available cash and the success of clinical trials.
